Tilgen W - Search Results

1

Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.

Reinhold U, Liu L, Lüdtke-Handjery HC, Heuser C, Hombach A, Wang X, Tilgen W, Ferrone S, Abken H. Reinhold U, et al. Among authors: tilgen w. J Invest Dermatol. 1999 May;112(5):744-50. doi: 10.1046/j.1523-1747.1999.00586.x. J Invest Dermatol. 1999. PMID: 10233766 Free article.

2

Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha.

Rappl G, Kapsokefalou A, Heuser C, Rössler M, Ugurel S, Tilgen W, Reinhold U, Abken H. Rappl G, et al. Among authors: tilgen w. J Invest Dermatol. 2001 Jan;116(1):102-9. doi: 10.1046/j.1523-1747.2001.00239.x. J Invest Dermatol. 2001. PMID: 11168804 Free article.

3

Upregulation of C4.4A expression during progression of melanoma.

Seiter S, Stassar M, Rappl G, Reinhold U, Tilgen W, Zöller M. Seiter S, et al. Among authors: tilgen w. J Invest Dermatol. 2001 Feb;116(2):344-7. doi: 10.1046/j.1523-1747.2001.01230.x. J Invest Dermatol. 2001. PMID: 11180013 Free article.

4

CD2-mediated CD59 stimulation in keratinocytes results in secretion of IL-1alpha, IL-6, and GM-CSF: implications for the interaction of keratinocytes with intraepidermal T lymphocytes.

Naderi S, Hofmann P, Seiter S, Tilgen W, Abken H, Reinhold U. Naderi S, et al. Among authors: tilgen w. Int J Mol Med. 1999 Jun;3(6):609-14. doi: 10.3892/ijmm.3.6.609. Int J Mol Med. 1999. PMID: 10341291

5

Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells.

Liu L, Abken H, Pföhler C, Rappl G, Tilgen W, Reinhold U. Liu L, et al. Among authors: tilgen w. Clin Exp Immunol. 2000 Jul;121(1):94-9. doi: 10.1046/j.1365-2249.2000.01260.x. Clin Exp Immunol. 2000. PMID: 10886244 Free PMC article.

6

CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.

Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S, Reinhold U. Rappl G, et al. Among authors: tilgen w. J Am Acad Dermatol. 2001 Mar;44(3):456-61. doi: 10.1067/mjd.2001.110900. J Am Acad Dermatol. 2001. PMID: 11209115

7

Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus.

Gross T, Wagner A, Ugurel S, Tilgen W, Reinhold U. Gross T, et al. Among authors: tilgen w. Dermatology. 2001;202(3):198-202. doi: 10.1159/000051636. Dermatology. 2001. PMID: 11385223

8

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.

Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Ugurel S, et al. Among authors: tilgen w. Cancer. 2001 Jul 15;92(2):369-76. doi: 10.1002/1097-0142(20010715)92:2<369::aid-cncr1332>3.0.co;2-u. Cancer. 2001. PMID: 11466692

9

HLA-G in melanoma: A new strategy to escape from immunosurveillance?

Ugurel S, Reinhold U, Tilgen W. Ugurel S, et al. Among authors: tilgen w. Onkologie. 2002 Apr;25(2):129-34. doi: 10.1159/000055222. Onkologie. 2002. PMID: 12006763 Review.

10

Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.

Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pföhler C. Ladewig G, et al. Among authors: tilgen w. Br J Dermatol. 2005 May;152(5):931-8. doi: 10.1111/j.1365-2133.2005.06480.x. Br J Dermatol. 2005. PMID: 15888149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters